HEALTHEQUITY, INC. 8-K

What Happened
HealthEquity, Inc. (HQY) filed an 8-K reporting results of its June 25, 2026 annual meeting of stockholders. As of the record date (May 6, 2026) 83,830,457 shares were outstanding and entitled to vote. Shareholders elected all ten director nominees—Robert Selander, Scott Cutler, Stephen Neeleman, M.D., Adrian Dillon, Evelyn Dilsaver, William Gassen, Debra McCowan, Rajesh Natarajan, Stuart Parker and Gayle Wellborn—and approved each proposal presented. The meeting ratified PricewaterhouseCoopers LLP as auditor and approved advisory pay, an Employee Stock Purchase Plan (ESPP) and an amended and restated 2024 Equity Incentive Plan. The 8-K was filed June 26, 2026 and signed by CFO James Lucania.

Key Details

• Record date and voting power: 83,830,457 shares issued and outstanding as of May 6, 2026.
• Director elections: all ten nominees elected; for-votes ranged roughly from 74.45M to 75.77M; each ballot showed 3,822,795 broker non-votes.
• Auditor ratification (Proposal 2): PwC ratified — 79,249,985 for, 449,600 against, 53,616 abstain (no broker non-votes).
• Advisory approval of executive compensation (say-on-pay, Proposal 3): 74,032,348 for, 1,852,931 against, 45,127 abstain; 3,822,795 broker non-votes.
• ESPP (Proposal 4): approved — 75,717,841 for, 190,964 against, 21,601 abstain; 3,822,795 broker non-votes.
• Amended & Restated 2024 Equity Incentive Plan (Proposal 5): approved — 73,514,259 for, 2,366,900 against, 49,247 abstain; 3,822,795 broker non-votes.

Why It Matters

• Governance continuity: Re-election of the board keeps current leadership and oversight in place, which can affect strategy and corporate oversight.
• Auditor and compensation approvals: Ratifying PwC maintains continuity of external financial oversight; advisory approval of pay (say-on-pay) indicates shareholder sentiment on executive compensation.
• Equity plans approved: Passing the ESPP and the amended equity incentive plan gives the company authority to grant employee equity and run the purchase plan, which affects employee compensation structure and potential future dilution.
• For investors: These are routine but material governance outcomes that confirm shareholder support for management’s compensation and equity programs and keep the company’s auditor and board in place.